Bicillin c-r 900/300 side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Bicillin c-r 900/300. Common side effects include drug hypersensitivity among females and pain among males.

The phase IV clinical study is created by eHealthMe based on 19 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 28, 2022

19 people who take Bicillin C-R 900/300 and have side effects are studied.


What is Bicillin C-R 900/300?

Bicillin c-r 900/300 has active ingredients of penicillin g benzathine; penicillin g procaine. eHealthMe is studying from 19 Bicillin c-r 900/300 users for its effectiveness, alternative drugs and more.

Number of Bicillin c-r 900/300 reports submitted per year:

Bicillin c-r 900/300 side effects.

Bicillin C-R 900/300 side effects by time on the drug*:

< 1 month:

  1. Dysstasia (difficulty in standing)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Drug hypersensitivity
  2. Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate)
  3. Embolia cutis medicamentosa (livedoid dermatitis occurs immediately after an intramuscular injection)
  4. Anaphylactic reaction (serious allergic reaction)
  5. Drug intolerance (drug sensitivity)
  6. Injection site pain
  7. Myelopathy (any neurologic deficit related to the spinal cord)
  8. Myositis (inflammation of the muscles)
  9. Neuromyopathy (disease of both muscles and nerves)
  10. Pain

Bicillin C-R 900/300 side effects by gender *:

female:

  1. Drug hypersensitivity
  2. Anaphylactic reaction (serious allergic reaction)
  3. Drug intolerance (drug sensitivity)
  4. Dysstasia (difficulty in standing)
  5. Embolia cutis medicamentosa (livedoid dermatitis occurs immediately after an intramuscular injection)
  6. Injection site pain
  7. Myelopathy (any neurologic deficit related to the spinal cord)

male:

  1. Pain
  2. Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate)

Bicillin C-R 900/300 side effects by age (0-1 to 60+) *:

0-1:

  1. Myelopathy (any neurologic deficit related to the spinal cord)
  2. Pain
  3. Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate)
  4. Embolia cutis medicamentosa (livedoid dermatitis occurs immediately after an intramuscular injection)

2-9:

  1. Myositis (inflammation of the muscles)

10-19:

n/a

20-29:

  1. Embolia cutis medicamentosa (livedoid dermatitis occurs immediately after an intramuscular injection)

30-39:

n/a

40-49:

  1. Drug hypersensitivity

50-59:

n/a

60+:

  1. Drug hypersensitivity

* Approximation only. Some reports may have incomplete information.

Do you take Bicillin c-r 900/300?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on penicillin g benzathine; penicillin g procaine (the active ingredients of Bicillin c-r 900/300) and Bicillin c-r 900/300 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Bicillin c-r 900/300:

All Bicillin c-r 900/300 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: